Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Breast Neoplasms × Radiosurgery × Clear all

Phase

Phase 2 15 Phase NA 11 Phase 1 6 Phase 3 5 Phase 1/2 3 Phase EARLY_PHASE1 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 4 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Radiotherapy 1 Lung Neoplasms 1 Gliosarcoma 1 Glioblastoma 1 Breast Neoplasms 1

Interventions

Fluorodeoxyglucose F18 7 Magnetic Resonance Spectroscopy 5 Letrozole 5 Blood Specimen Collection 5 pembrolizumab 4 atezolizumab 4 Trastuzumab 4 Oncolytic Virotherapy 3 Fish Oils 3 Docosahexaenoic Acids 3 Carboplatin 3 Bevacizumab 3 pertuzumab 2 palbociclib 2 Vitamin D 2 Taxes 2 Sentinel Lymph Node Biopsy 2 Saline Solution 2 Radiotherapy 2 Positron Emission Tomography Computed Tomography 2 Paclitaxel 2 Neoadjuvant Therapy 2 Metformin 2 Lapatinib 2 Fulvestrant 2 Cyclophosphamide 2 Biopsy 2 Albumin-Bound Paclitaxel 2 68Ga-NOTA-RM26 2 trastuzumab biosimilar HLX02 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03295916 2020-01-29

STOMP

Juravinski Cancer Center

Phase EARLY_PHASE1 Unknown

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡